124 related articles for article (PubMed ID: 3141096)
1. The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients.
Elliott CR; Pater JL
Clin Invest Med; 1988 Oct; 11(5):327-30. PubMed ID: 3141096
[TBL] [Abstract][Full Text] [Related]
2. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
Louie TJ; Chubb H; Bow EJ; Conly JM; Harding GK; Rayner E; James M
Rev Infect Dis; 1985; 7 Suppl 4():S747-61. PubMed ID: 3909333
[TBL] [Abstract][Full Text] [Related]
3. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
4. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
5. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
[TBL] [Abstract][Full Text] [Related]
6. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
Fainstein V; Bodey GP; Bolivar R; Elting L; McCredie KB; Keating MJ
Arch Intern Med; 1984 Sep; 144(9):1766-70. PubMed ID: 6383246
[TBL] [Abstract][Full Text] [Related]
7. Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection.
Bow EJ; Louie TJ
CMAJ; 1987 Sep; 137(5):397-403. PubMed ID: 3304600
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
[TBL] [Abstract][Full Text] [Related]
9. Etiology of infections in neutropenic patients with acute leukemia. Results of two antibiotic combinations.
Scaglione C; López H; Fernández A; Marcenac F; Garay G; Dupont J; Pavlovsky S
Medicina (B Aires); 1981; 41 Suppl():29-34. PubMed ID: 6954341
[No Abstract] [Full Text] [Related]
10. A study of various antibiotic combinations for the empiric treatment of neutropenic febrile children.
Anak S; Devecioğlu O; Ağaoğlu L; Zülfikar B; Ayan I; Atilgan N; Yalman N; Bilgen H; Kaya G; Gedikoğlu G
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():104. PubMed ID: 2697388
[No Abstract] [Full Text] [Related]
11. [Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors].
Natali M; Tonini G; Tufo E; Leggio M; Carassai A; Lopez M
Clin Ter; 1989 Sep; 130(5):239-44. PubMed ID: 2530024
[TBL] [Abstract][Full Text] [Related]
12. Emergence of tobramycin-resistant S. epidermidis possessing aminoglycoside modifying enzymes and bacteremic superinfection during empiric therapy of febrile neutropenic episodes.
Riben PD; Horsman GB; Rayner E; Irvine-Meek J; Urias B; Albritton WL; deSaxe MJ; Ronald AR; Louie TJ
Clin Invest Med; 1985; 8(4):272-85. PubMed ID: 3907919
[TBL] [Abstract][Full Text] [Related]
13. Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical survey.
Pater JL; Weir L
J Clin Oncol; 1986 Mar; 4(3):346-52. PubMed ID: 3512784
[TBL] [Abstract][Full Text] [Related]
14. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
[TBL] [Abstract][Full Text] [Related]
15. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
16. Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
Parr MD; Waite WW; Hansen LA; McDaniel PA
Am J Hosp Pharm; 1985 Nov; 42(11):2484-8. PubMed ID: 4073066
[TBL] [Abstract][Full Text] [Related]
17. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H;
Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis and treatment of bacterial infections: do we need new strategies?
Micozzi A; Bucaneve G
Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
[TBL] [Abstract][Full Text] [Related]
19. Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.
Jones P; Rolston K; Fainstein V; Elting L; Bodey GP
Rev Infect Dis; 1985; 7 Suppl 4():S741-6. PubMed ID: 3909332
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
